The Role of the SLC Transporters Protein in the Neurodegenerative Disorders

키워드

참고문헌 (82)

1. Hediger MA, "The ABCs of membrane transporters in health and disease(SLC series) : introduction", Mol Aspects Med, 34, pp.95~107 (2012)
2. Lin L, "SLC transporters as therapeutic targets : emerging opportunities", Nat Rev Drug Discov, 14, pp.543~560 (2015)
3. Bai X, "Structural biology of solute carrier(SLC)membrane transport proteins", Mol Membr Biol, 13, pp.1~32 (2018)
4. Simpson IA, "Supply and demand in cerebral energy metabolism : the role of nutrient transporters", J Cereb Blood Flow Metab, 27, pp.1766~1791 (2007)
5. Brunton LL, "Goodman & Gilman’s : the pharmacological basis of therapeutics" (2008), McGraw-Hill
6. Mueckler M, "The SLC2(GLUT)family of membrane transporters", Mol Aspects Med, 34, pp.121~138 (2013)
7. Wright EM, "Glucose transport families SLC5 and SLC50", Mol Aspects Med, 34, pp.183~196 (2013)
8. Kanai Y, "Primary structure and functional characterization of a high-affinity glutamate transporter", Nature, 360, pp.467~471 (1992)
9. Kanai Y, "The glutamate", neutral amino acid transporter family SLC1 : molecular, physiological and pharmacological aspects, 2004, pp.447, 469~479
10. Xu Y, "SLC1A2rs3794087 are associated with susceptibility to Parkinson’s disease, but not essential tremor, amyotrophic lateral sclerosis or multiple system atrophy in a Chinese population", J Neurol Sci, 365, pp.96~100 (2016)
11. Tanaka K, "Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1", Science, 276, pp.1699~1702 (1997)
12. Arriza JL, "Cloning and expression of a human neutral amino acid transporter with structural similarity to the glutamate transporter gene family", J Biol Chem, 268, pp.15329~15332 (1993)
13. Shafqat S, "Cloning and expression of a novel Na＋-dependent neutral amino acid transporter structurally related to mammalian Na＋", glutamate cotransporters, 1993, pp.268, 15351~15355
14. Sakai K, "Neutral amino acid transporter ASCT1 is preferentially expressed in L-Ser-synthetic", storing glial cells in the mouse brain with transient expression in developing capillaries, 2003, pp.23, 550~560
15. Utsunomiya-Tate N, "Cloning and functional characterization of a system ASC-like Na＋-dependent neutral amino acid transporter", J Biol Chem, 271, pp.14883~14890 (1996)
16. Bröer A, "Neutral amino acid transporter ASCT2 displays substrate-induced Na＋ exchange and a substrate-gated anion conductance", Biochem J, 346(Pt 3), pp.705~710 (2000)
17. Fairman WA, "An excitatory amino-acid transporter with properties of a ligand-gated chloride channel", Nature, 375, pp.599~603 (1995)
18. Nagao S, "EAAT4, a glutamate transporter with properties of a chloride channel, is predominantly localized in Purkinje cell dendrites, and forms parasagittal compartments in rat cerebellum", Neuroscience, 78, pp.929~933 (1997)
19. Romero MF, "The SLC4 family of bicarbonate(HCO3−)transporters", Mol Aspects Med, 34, pp.159~182 (2013)
20. Alka K, "Bicarbonate transport in health and disease", IUBMB Life, 66, pp.596~615 (2014)
21. Kristensen AS, "SLC6 neurotransmitter transporters : structure, function, and regulation", Pharmacol Rev, 63, pp.585~640 (2011)
22. Fotiadis D, "The SLC3 and SLC7 families of amino acid transporters", Mol Aspects Med, 34, pp.139~158 (2013)
23. Scalise M, "The human SLC7A5(LAT1) : the intriguing histidine", large neutral amino acid transporter and its relevance to human health, 2018, pp.6, 243~
24. Berg D, "Brain iron pathways and their relevance to Parkinson’s disease", J Neurochem, 79, pp.225~236 (2001)
25. Thomas M, "Neurodegenerative disease and iron storage in the brain", Curr Opin Neurol, 17, pp.437~442 (2004)
26. Salazar J, "Divalent metal transporter 1(DMT1)contributes to neurodegeneration in animal models of Parkinson’s disease", Proc Natl Acad Sci U S A, 105, pp.18578~18583 (2008)
27. Zheng Z, "Altered microglial copper homeostasis in a mouse model of Alzheimer’s disease", J Neurochem, 114, pp.1630~1638 (2010)
28. Arroyo JP, "The SLC12 family of electroneutral cation-coupled chloride cotransporters", Mol Aspects Med, 34, pp.288~298 (2013)
29. Hagenbuch B, "The SLCO(former SLC21)superfamily of transporters", Mol Aspects Med, 34, pp.396~412 (2013)
30. Roth M, "OATPs, OATs and OCTs : the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies", Br J Pharmacol, 165, pp.1260~1287 (2012)
31. Vallon V, "A role for the organic anion transporter OAT3 in renal creatinine secretion in mice", Am J Physiol Renal Physiol, 302, pp.F1293~F1299 (2012)
32. Schmitt A, "Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice", J Neurosci Res, 71, pp.701~709 (2003)
33. Haitina T, "Fourteen novel human members of mitochondrial solute carrier family 25(SLC25)widely expressed in the central nervous system", Genomics, 88, pp.779~790 (2006)
34. Mao W, "UCP4, a novel brain-specific mitochondrial protein that reduces membrane potential in mammalian cells", FEBS Lett, 443, pp.326~330 (1999)
35. Sanchis D, "BMCP1, a novel mitochondrial carrier with high expression in the central nervous system of humans and rodents, and respiration uncoupling activity in recombinant yeast", J Biol Chem, 273, pp.34611~34615 (1998)
36. Richard D, "Uncoupling protein 2 in the brain : distribution and function", Biochem Soc Trans, 29(Pt 6), pp.812~817 (2001)
37. Arsenijevic D, "Disruption of the uncoupling protein-2gene in mice reveals a role in immunity and reactive oxygen species production", Nat Genet, 26, pp.435~439 (2006)
38. Kim-Han JS, "BMCP1 : a mitochondrial uncoupling protein in neurons which regulates mitochondrial function and oxidant production", J Neurochem, 79, pp.658~668 (2001)
39. Li Z, "The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses", Cell, 119, pp.873~887 (2004)
40. Schweigel-Röntgen M, "The families of zinc(SLC30 and SLC39)and copper(SLC31)transporters", Curr Top Membr, 73, pp.321~355 (2004)
41. Adlard PA, "Cognitive loss in zinc transporter-3 knock-out mice: a phenocopy for the synaptic and memory deficits of Alzheimer’s disease?", J Neurosci, 30, pp.1631~1636 (2010)
42. Lovell MA, "Alterations in zinc transporter protein-1(ZnT-1)in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer’s disease", Neurotox Res, 7, pp.265~271 (2005)
43. Nevitt T, "Charting the travels of copper in eukaryotes from yeast to mammals", Biochim Biophys Acta, 1823, pp.1580~1593 (2012)
44. Schweigel-Röntgen M, "SLC41 transporters--molecular identification and functional role", Curr Top Membr, 73, pp.383~410 (2014)
45. Lang M, "Genetic inhibition of solute-linked carrier 39 family transporter 1 ameliorates aβ pathology in a Drosophila model of Alzheimer’s disease", PLoS Genet, 8, pp.e1002683~ (2012)
46. Donato F, "Parvalbumin-expressing basket-cell network plasticity induced by experience regulates adult learning", Nature, 504, pp.272~276 (2013)
47. Garcia-Esparcia P, "Glutamate transporter GLT1 expression in Alzheimer disease and dementia with Lewy bodies", Front Aging Neurosci, 10, pp.112~ (2018)
48. Go S, "Protective function of SLC30A10 induced via PERK-ATF4pathway against 1-methyl-4-phenylpyridinium", Biochem Biophys Res Commun, 490, pp.1307~1313 (2017)
49. Jamieson SE, "Candidate gene association study of solute carrier family 11a members 1(SLC11A1)and 2(SLC11A2)genes in Alzheimer’s disease", Neurosci Lett, 374, pp.124~128 (2005)
50. Häggmark A, "Plasma profiling reveals three proteins associated to amyotrophic lateral sclerosis", Ann Clin Transl Neurol, 1, pp.544~553 (2014)
51. Paez-Colasante X, "Amyotrophic lateral sclerosis : mechanisms and therapeutics in the epigenomic era", Nat Rev Neurol, 11, pp.266~279 (2015)
52. Carbone M, "Riluzole elevates GLT-1 activity and levels in striatal astrocytes", Neurochem Int, 60, pp.31~38 (2012)
53. Dall’Igna OP, "Riluzole increases glutamate uptake by cultured C6 astroglial cells", Int J Dev Neurosci, 31, pp.482~486 (2013)
54. Woltjer RL, "Aberrant detergent-insoluble excitatory amino acid transporter 2 accumulates in Alzheimer disease", J Neuropathol Exp Neurol, 69, pp.667~676 (2010)
55. Guo H, "Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice", Hum Mol Genet, 12, pp.2519~2532 (2003)
56. Rothstein JD, "Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis", Ann Neurol, 38, pp.73~84 (1995)
57. Karki P, "Genetic dys-regulation of astrocytic glutamate transporter EAAT2 and its implications in neurological disorders and manganese toxicity", Neurochem Res, 40, pp.380~388 (2015)
58. Kong Q, "Small-molecule activator of glutamate transporter EAAT2translation provides neuroprotection", J Clin Invest, 124, pp.1255~1267 (2014)
59. Sasaki S, "Ultrastructural change of synapses of Betz cells in patients with amyotrophic lateral sclerosis", Neurosci Lett, 268, pp.29~32 (1999)
60. Wong PC, "An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria", Neuron, 14, pp.1105~1116 (1995)
61. Dargaei Z, "Restoring GABAergic inhibition rescues memory deficits in a Huntington’s disease mouse model", Proc Natl Acad Sci U S A, 115, pp.E1618~E1626 (2018)
62. Begeti F, "Hippocampal dysfunction defines disease onset in Huntington’s disease", J Neurol Neurosurg Psychiatry, 87, pp.975~981 (2016)
63. Lemiere J, "Cognitive changes in patients with Huntington’s disease(HD)and asymptomatic carriers of the HD mutation--a longitudinal follow-up study", J Neurol, 251, pp.935~942 (2004)
64. Paulsen JS, "Cognitive impairment in Huntington disease : diagnosis and treatment", Curr Neurol Neurosci Rep, 11, pp.474~483 (2011)
65. Usdin MT, "Impaired synaptic plasticity in mice carrying the Huntington’s disease mutation", Hum Mol Genet, 8, pp.839~846 (1999)
66. Lynch G, "Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington’s disease", J Neurosci, 27, pp.4424~4434 (2007)
67. Simmons DA, "Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington’s disease knockin mice", Proc Natl Acad Sci U S A, 106, pp.4906~4911 (2009)
68. Kolodziejczyk K, "Striatal synaptic dysfunction and hippocampal plasticity deficits in the Hu97", 18 mouse model of Huntington disease, 2014, pp.9, e94562~
69. Lione LA, "Selective discrimination learning impairments in mice expressing the human Huntington’s disease mutation", J Neurosci, 19, pp.10428~10437 (1999)
70. Habak C, "Dopamine transporter SLC6A3genotype affects cortico-striatal activity of set-shifts in Parkinson’s disease", Brain, 137(Pt 11), pp.3025~3035 (2014)
71. Li J, "Identification of critical genes and miRNAs associated with the development of Parkinson’s disease", J Mol Neurosci, 65, pp.527~535 (2018)
72. Majoor-Krakauer D, "Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson’s disease : evidence of shared genetic susceptibility", Neurology, 44, pp.1872~1877 (1994)
73. Gilbert RM, "Parkinsonism and motor neuron diseases : twenty-seven patients with diverse overlap syndromes", Mov Disord, 25, pp.1868~1875 (2010)
74. Gouras GK, "Convergence of synapses, endosomes, and prions in the biology of neurodegenerative diseases", Int J Cell Biol, 2013, pp.e141083~ (2013)
75. Montalbetti N, "Mammalian iron transporters : families SLC11 and SLC40", Mol Aspects Med, 34, pp.270~287 (2013)
76. Haase J, "Integrating the monoamine, neurotrophin and cytokine hypotheses of depression--a central role for the serotonin transporter?", Pharmacol Ther, 147, pp.1~11 (2015)
77. Harvey RJ, "Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain", Nat Rev Drug Discov, 12, pp.866~885 (2013)
78. Santarelli S, "The amino acid transporter SLC6A15 is a regulator of hippocampal neurochemistry and behavior", J Psychiatr Res, 68, pp.261~269 (2015)
79. Li L, "The association between genetic variants in the dopaminergic system and posttraumatic stress disorder: a meta-analysis", Medicine (Baltimore), 95, pp.e3074~ (2016)
80. Chang SC, "Molecular variation at the SLC6A3 locus predicts lifetime risk of PTSD in the Detroit Neighborhood Health Study", PLoS One, 7, pp.e39184~ (2012)
81. Zelano J, "The synaptic protein encoded by the gene Slc10A4 suppresses epileptiform activity and regulates sensitivity to cholinergic chemoconvulsants", Exp Neurol, 239, pp.73~81 (2013)
82. Bröer S, "The solute carrier 6 family of transporters", Br J Pharmacol, 167, pp.256~278 (2012)

관련 논문AI추천